Kevin Young
2007
In 2007, Kevin Young earned a total compensation of $4.2M as Executive Vice President, Commercial Operations at Gilead Sciences, a 25% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $445,200 |
|---|---|
| Option Awards | $2,590,324 |
| Salary | $527,500 |
| Stock Awards | $604,909 |
| Other | $26,755 |
| Total | $4,194,688 |
Young received $2.6M in option awards, accounting for 62% of the total pay in 2007.
Young also received $445.2K in non-equity incentive plan, $527.5K in salary, $604.9K in stock awards and $26.8K in other compensation.
Rankings
In 2007, Kevin Young's compensation ranked 1,024th out of 8,700 executives tracked by ExecPay. In other words, Young earned more than 88.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,024 out of 8,700 | 88th |
Division Manufacturing | 359 out of 3,314 | 89th |
Major group Chemicals And Allied Products | 69 out of 746 | 91st |
Industry group Drugs | 41 out of 546 | 93rd |
Industry Biological Products, Except Diagnostic Substances | 7 out of 118 | 94th |
Source: SEC filing on March 12, 2009.
Young's colleagues
We found five more compensation records of executives who worked with Kevin Young at Gilead Sciences in 2007.
2007
John Martin
Gilead Sciences
Chief Executive Officer
2007
John Milligan
Gilead Sciences
Chief Operating Officer
2007
Norbert Bischofberger
Gilead Sciences
Chief Scientific Officer
2007
Gregg Alton
Gilead Sciences
General Counsel
2007
Caroline Dorsa
Gilead Sciences